| Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink | Frank Vinluan | 12/11/19 | National |
| Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More | Sarah de Crescenzo | 12/06/19 | National |
| Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More | Frank Vinluan | 11/22/19 | National |
| Biopharma Execs Remain Optimistic Despite Political Headwinds | Mike Ward | 11/20/19 | National |
| Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | Sarah de Crescenzo | 11/15/19 | National |
| Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange | Frank Vinluan | 11/11/19 | San Francisco |
| Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More | Frank Vinluan | 11/08/19 | National |
| AI Can Unlock Health Data’s Potential, But Access Is Still Difficult | Jeff Bauter Engel | 11/07/19 | Wisconsin |
| AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund | Gareth Macdonald | 11/06/19 | National |
| GE Healthcare Opens Startup Labs at Former AstraZeneca UK R&D Site | Dan Stanton | 11/06/19 | National |
| Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More | Frank Vinluan | 11/01/19 | National |
| FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns | Frank Vinluan | 10/30/19 | National |
| Venture Investors Bets on Healthcare, and Milwaukee, With $75M Fund | Jeff Bauter Engel | 10/28/19 | Wisconsin |
| Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More | Sarah de Crescenzo | 10/25/19 | National |
| Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More | Frank Vinluan | 10/18/19 | National |
| Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices | Jeff Bauter Engel | 10/17/19 | Boston |
| Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More | Alex Lash | 10/11/19 | National |
| The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It? | Alex Lash | 10/10/19 | National |
| WI Watchlist: Epic, Shine, Venture Investors, Stratatech & More | Jeff Bauter Engel | 10/09/19 | Wisconsin |
| Five Years After Y Combinator First Admits Biotechs, They’re Dug In | Bernadette Tansey | 10/09/19 | San Francisco |
| Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels | Frank Vinluan | 10/07/19 | National |
| Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates | Jeff Bauter Engel | 10/04/19 | Wisconsin |
| Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More | Ben Fidler | 10/04/19 | National |
| Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto | Bernadette Tansey | 10/02/19 | San Francisco |
| ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More | Ben Fidler | 10/01/19 | National |
| Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More | Frank Vinluan | 09/27/19 | National |
| Report: IPO Activity Picking Back Up Following Quiet, Volatile Q3 | Sarah de Crescenzo | 09/25/19 | San Diego |
| FDA Decision Expands Market for Exact Sciences’ Cologuard Test | Jeff Buchanan | 09/23/19 | Wisconsin |
| Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More | Alex Lash | 09/20/19 | National |
| Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation? | Alex Lash | 09/19/19 | National |
